Pneumosil

BIOLOGICAL2 trials

Sponsors

PATH

Conditions

Pneumonia, Pneumococcal

Phase 3

Phase 3 Study of 10-valent Pneumococcal Conjugate Vaccine (PNEUMOSIL) in Healthy Infants

CompletedNCT03197376

PATHPneumonia, Pneumococcal

Start: 2017-06-21End: 2019-05-09Updated: 2020-07-14

Study of 10-valent Pneumococcal Conjugate Vaccine (Pneumosil) Administered in a 2+1 Schedule to Healthy Infants

CompletedNCT03896477

PATHPneumonia, Pneumococcal

Start: 2019-07-18End: 2020-12-17Updated: 2022-04-20

Related Papers

Booster Vaccination against Yellow Fever in Gambian children-(BoVY) -a Phase 3 clinical trial to establish safety and immunogenicity of repeated YF vaccination in healthy Gambian children of different ages.

2024-12-241 citations

Immunogenicity and safety of a 10-valent pneumococcal conjugate vaccine administered as a 2 + 1 schedule to healthy infants in The Gambia: a single-centre, double-blind, active-controlled, randomised, phase 3 trial.

2023-01-108 citations

Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial.

2021-01-2827 citations